StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Bristol-Myers Squibb Co. (BMY) PT Raised to $57 at Goldman Sachs
July 29, 2024 7:18 AM
Goldman Sachs analyst Chris Shibutani raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $57.00 (from $55.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Bristol-Myers Squibb Co. (BMY) PT Lowered to $62 at Truist Securities
July 29, 2024 7:02 AM
Barclays Downgrades Bristol-Myers Squibb Co. (BMY) to Underweight
July 29, 2024 5:36 AM
Bristol-Myers Squibb Co. (BMY) PT Raised to $50 at Cantor Fitzgerald
July 26, 2024 1:39 PM
Form 10-Q BRISTOL MYERS SQUIBB CO For: Jun 30
July 26, 2024 12:05 PM
Bristol-Myers Squibb (BMY) stock gains after raising full-year guidance
July 26, 2024 7:51 AM
Midday movers: Bristol-Myers, 3M and Deckers rise; Dexcom falls
July 26, 2024 7:47 AM
Form 8-K BRISTOL MYERS SQUIBB CO For: Jul 26
July 26, 2024 7:47 AM
Bristol-Myers Squibb (BMY) Tops Q2 EPS by 43c, provides guidance
July 26, 2024 7:02 AM
Bristol Myers second-quarter results beat expectations, helped by new drugs
July 26, 2024 7:00 AM
Bristol Myers Squibb Reports Second Quarter Financial Results for 2024
July 26, 2024 6:59 AM
PCE release, Apple's Chinese sales, European earnings - what's moving markets
July 26, 2024 4:12 AM
